Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer

被引：0

作者：

Toth, Richard ^{[1
]}

机构：

[1] Semmelweis Univ, Budapest, Hungary

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9 / 9

页数：1

共 50 条

[1] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Schutz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : 11 - 11
[2] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Schutz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : 12 - 12
[3] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Schutz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : 11 - 11
[4] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Schuetz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_1) : 10 - 10
[5] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Yaznil, Muhammad Rizki
Drews, Florian
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 14 - 15
[6] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Toth, Richard
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 : 9 - 9
[7] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Schuetz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : 10 - 10
[8] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Schuetz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : 11 - 11
[9] Emerging molecular-targeted therapies or early preclinical trials in ovarian cancer
Drews, Florian
Schutz, Anna-Maria
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 13 - 13
[10] Emerging molecular-targeted therapies or early preclinical trials in cervical cancer
Mardas, Marcin
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 34 - 34

← 1 2 3 4 5 →